Sharon Mates - Chairman and CEO, Director at Intra-Cellular Therapies, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman and CEO, Director
Stock Symbol
ITCI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Sharon Mates - trading volume in the past year for Intra-Cellular Therapies, Inc.

Holdings reported by Sharon Mates for Intra-Cellular Therapies, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.07M $78.5M $73.32 Aug 30, 2024 Direct
Restricted Stock Units 20.6K $1.38M $67.12 Mar 10, 2024 Direct Common Stock
Stock Option (right to buy) 103K Aug 30, 2024 Direct Common Stock

Transactions reported by Sharon Mates for Intra-Cellular Therapies, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.